MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    T1 MRI reveals differential hippocampal atrophy in Lewy body disorders with and without Alzheimer’s copathology

    J. Cohen, J. Phillips, S. Das, E. Rhodes, K. Cousins, P. Yushkevich, D. Wolk, D. Weintraub, D. Irwin, C. Mcmillan (Philadelphia, USA)

    Objective: Determine whether MRI can identify differences in hippocampal volume between patients with Lewy body disorders with and without Alzheimer's copathology, and whether these differences…
  • 2023 International Congress

    Spiral drawing features are similar between essential tremor and essential tremor plus

    R. Anandapadmanabhan, A. Vishnoi, A. Latorre, N. Thirugnanasambandam, A. Dipani, D. Biswas, A. Srivastava, K. Bhatia, R. Rajan (New Delhi, India)

    Objective: To explore the features on free hand spirals drawn by patients with essential tremor and essential tremor plus. Background: The 2018 consensus statement on…
  • 2023 International Congress

    Initial clinical experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson´s disease in Croatia

    P. Bago Rožanković, S. Lasić, F. Borovečki, S. Telarović, R. Perković, V. Vuletić, O. Perković, V. Rački, S. Tomić (Zagreb, Croatia)

    Objective: To report preliminary results of a 12-week, prospective, multicenter, observational study of the efficacy and safety of LECIG for the treatment of advanced Parkinson´s…
  • 2023 International Congress

    Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study

    ���N. Likhitwitayawuid, Y. Pitakpatapee, W. Saengphatarachai, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: The primary aim was translation to thai and cognitive debriefing of the thai version of the hfs score in patients with hfs. The secondary…
  • 2023 International Congress

    Voice- tremor in a patient with positive VPS 16 nonsense mutation: Expanding the phenotype

    K. Kunj, A. Das, A. Srivastava (New Delhi, India)

    Objective: Reporting a case of voice-tremor in a patient with heterozygous non-sense variation in exon 16 of VPS 16 gene Background: Dystonia-30 is caused by…
  • 2023 International Congress

    Data-driven subtypes of multiple system atrophy and the implication on prognosis

    C-C. Fan, C. Han, X-M. Wang, W. Mao, E-H. Xu, P. Chan, S-Y. Liu (Beijing, China)

    Objective: To determine the clinical subtypes of MSA using data-driven approach and to compare the differences of the subtypes on survival and bed-ridden rates. Background:…
  • 2023 International Congress

    Focused ultrasound as rescue treatment of essential tremor after deep brain stimulation.

    D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. Gonzalez, S. Jaume, G. Plans, R. Alvarez (Badalona, Spain)

    Objective: To describe a case of disabling essential tremor (ET) treated with unilateral MRI-Guided Focused Ultrasound (FUS) thalamotomy as rescue treatment after deep brain stimulation…
  • 2023 International Congress

    Sensor-based digital measurement of gait and wrist pronation-supination in clinically-defined classes of Parkinson’s disease progression identified by unsupervised clustering

    D. Rodriguez Duque, J. Edgerton, L. Zhu, C. Kanzler, C. de Moor, S. Belachew, T. Dam, T. Liu, C. Shen, M. Yang, F. Nahab (Cambridge, USA)

    Objective: To determine how sensor-based measurement of motor performances relate to the heterogeneity of clinical progression in early Parkinson’s disease (PD). Background: Observed disease progression…
  • 2023 International Congress

    A 16-week open-label study of the effects of treatment with pimavanserin on activities of daily living in subjects with Parkinson’s disease psychosis (PDP)

    V. Evidente, D. Dekarske, B. Coate, V. Abler (Scottsdale, USA)

    Objective: To examine the effects of pimavanserin on activities of daily living during treatment for Parkinson’s Disease psychosis. Background: Accurate assessment of disability associated with…
  • 2023 International Congress

    Dopaminergic neuronal cell therapy for Parkinson’s Disease: results from a phase 1 study of Bemdaneprocel

    C. Henchcliffe, H. Sarva, A. Lozano, A. Fasano, S. Kalia, C. Brennan, K. Yu, M. Yountz, A. Enayetallah, A. Lampron, V. Tabar (Orange, USA)

    Objective: This first-in-human Phase 1 study aims to assess the safety, tolerability, clinical efficacy, and functional imaging measures of bemdaneprocel in subjects with PD. Background:…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley